DAVID M. STACK - 11 Jan 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: CEO and Chairman, Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 11 Jan 2022
Net transactions value: +$162,150
Form type: 4
Filing time: 13 Jan 2022, 15:11:37 UTC
Previous filing: 18 Nov 2021
Next filing: 27 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Options Exercise	$162,150	+15,000	+16%	$10.81	109,374	11 Jan 2022	Direct	F1
holding	PCRX	Common Stock						97,273	11 Jan 2022	By Three Colleens Investment, LLC	F2
holding	PCRX	Common Stock						18,596	11 Jan 2022	By Stack Schroon Mohawk FLP	F2
holding	PCRX	Common Stock						315	11 Jan 2022	LCK Investment LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-15,000	-20%	$0.000000	58,670	11 Jan 2022	Common Stock	15,000	$10.81	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 289 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021.
F2	Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F3	The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.